Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Aldape

Showing results (261-270 of 345) with videos related to

Pageof 35
Sort By:
Journal of Neuropathology and Experimental Neurology|April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
Brain Pathology (Zurich, Switzerland)|July 7, 2016
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcomePascal D Johann, Volker Hovestadt, Christian Thomas, et al.
JAMA Oncology|January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
JCO Precision Oncology|September 6, 2021
Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in GlioblastomaYing Pang, Guangyang Yu, Madison Butler, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Genes & Development|April 8, 2024
Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotypeNicholas Nuechterlein, Allison Shelbourn, Frank Szulzewsky, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Neuro-Oncology|September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnosticsZhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Pageof 35

Showing results (261-270 of 345) with videos related to

Sort By:
Pageof 35
Journal of Neuropathology and Experimental Neurology|April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
Brain Pathology (Zurich, Switzerland)|July 7, 2016
Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcomePascal D Johann, Volker Hovestadt, Christian Thomas, et al.
JAMA Oncology|January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
JCO Precision Oncology|September 6, 2021
Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in GlioblastomaYing Pang, Guangyang Yu, Madison Butler, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Genes & Development|April 8, 2024
Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotypeNicholas Nuechterlein, Allison Shelbourn, Frank Szulzewsky, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Neuro-Oncology|September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnosticsZhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Pageof 35